|Articles|March 19, 2020

David L. Nathan Joins Cannabis Science and Technology’s Editorial Advisory Board

Cannabis Science and Technology is pleased to announce the addition of David L. Nathan MD, DFAPA to its editorial advisory board (EAB).

Cannabis Science and Technology is pleased to announce the addition of David L. Nathan MD, DFAPA to its editorial advisory board (EAB).

Located in Princeton, New Jersey, Dr. Nathan is a psychiatrist, writer, speaker, educator, and consultant. Among his many talents, Dr. Nathan founded Doctors for Cannabis Regulation (DFCR), where he also holds the title of board president. He is also a founding steering committee member of New Jersey United for Marijuana Reform. In 2019, Dr. Nathan was one of two physicians to testify at the first United States House Judiciary Committee hearing regarding cannabis legislation.

Dr. Nathan graduated magna cum laude from Princeton University and he received his MD from the University of Pennsylvania School of Medicine. He then went on to complete his psychiatry residency at McLean Hospital of Harvard Medical School. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association, Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School, and a community fellow at Mathey College of Princeton University.

Dr. Nathan has written and spoken extensively on cannabis policy, with audiences ranging from lawmakers, businesspeople, state medical societies, hospital medical staff, allied health professionals, and the lay public. He has testified before eight state legislatures and the U.S. Congress, and he coauthored a landmark article on cannabis regulation with former Surgeon General Joycelyn Elders for the American Journal of Public Health.

Dr. Nathan has appeared in nationally syndicated broadcast, online and print media publications, with more prominent outlets including CNN, The New York Times, Wall Street Journal, Washington Post, US News & World Report, VICE News, San Francisco Chronicle, Politico, The Week (UK), and SinoVision News. He has also appeared in many state, province, and local media outlets around the United States and Canada.

Dr. Nathan serves as a cannabis consultant for government and industry. He is currently the Chief Medical Advisor for 4Front Ventures, a multistate medical cannabis company.

During his free time, Dr. Nathan publishes articles on a variety of historical subjects such as early written language, numismatics, animation, and the dawn of American football.


Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!